Caloric Restriction Rejuvenates Skeletal Muscle Growth in Heart Failure With Preserved Ejection Fraction.

HFpEF diet exercise training mitochondria skeletal muscle

Journal

JACC. Basic to translational science
ISSN: 2452-302X
Titre abrégé: JACC Basic Transl Sci
Pays: United States
ID NLM: 101677259

Informations de publication

Date de publication:
Feb 2024
Historique:
received: 07 07 2023
revised: 22 09 2023
accepted: 25 09 2023
medline: 21 3 2024
pubmed: 21 3 2024
entrez: 21 3 2024
Statut: epublish

Résumé

Heart failure with preserved ejection fraction (HFpEF) is a major clinical problem, with limited treatments. HFpEF is characterized by a distinct, but poorly understood, skeletal muscle pathology, which could offer an alternative therapeutic target. In a rat model, we identified impaired myonuclear accretion as a mechanism for low myofiber growth in HFpEF following resistance exercise. Acute caloric restriction rescued skeletal muscle pathology in HFpEF, whereas cardiac therapies had no effect. Mechanisms regulating myonuclear accretion were dysregulated in patients with HFpEF. Overall, these findings may have widespread implications in HFpEF, indicating combined dietary with exercise interventions as a beneficial approach to overcome skeletal muscle pathology.

Identifiants

pubmed: 38510717
doi: 10.1016/j.jacbts.2023.09.014
pii: S2452-302X(23)00462-X
pmc: PMC10950401
doi:

Types de publication

Journal Article

Langues

eng

Pagination

223-240

Informations de copyright

© 2024 The Authors.

Déclaration de conflit d'intérêts

Dr Espino-Gonzalez is a recipient of a doctoral fellowship from the Mexican National Council of Science and Technology (CONACYT). Dr Altara’s work was supported by a grant from the K.G. Jebsen Center for Heart Failure Research. Dr Cheng is supported by BHF Mautner Career Development Fellowship. Dr Justo da Silva was supported by the South-Eastern Norway Regional Health Authority (HSØ-RHF, Project No. 25674). Dr Booz has received support from the Pharmacology Clinical Research Core of the University of Mississippi Medical Center School of Medicine. Dr Bowen has received funding from the Medical Research Council (UK) (MR/S025472/1) and Heart Research UK (TRP16/19). All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Auteurs

Ever Espino-Gonzalez (E)

School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.

Peter G Tickle (PG)

School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.

Raffaele Altara (R)

Department of Anatomy & Embryology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands.
Department of Pathology, School of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA.

Harrison Gallagher (H)

School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.

Chew W Cheng (CW)

Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine, University of Leeds, Leeds, United Kingdom.

Viktor Engman (V)

School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.

Nathanael Wood (N)

School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.

Gustavo Jose Justo da Silva (GJ)

Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Oslo, Norway.

Mattia Scalabrin (M)

School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.

Xinyue Yu (X)

School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.

Ziyi Zhong (Z)

School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.

Michael A Colman (MA)

School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.

Nadira Y Yuldasheva (NY)

Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine, University of Leeds, Leeds, United Kingdom.

George W Booz (GW)

Department of Pharmacology and Toxicology, School of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA.

Volker Adams (V)

Heart Center Dresden, TU-Dresden, Dresden, Germany.

Marcelo G Pereira (MG)

School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.

Alessandro Cataliotti (A)

Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Oslo, Norway.

Lee D Roberts (LD)

Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine, University of Leeds, Leeds, United Kingdom.

Stuart Egginton (S)

School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.

T Scott Bowen (TS)

School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.

Classifications MeSH